JPetroInc Saturday, 12/26/20 09:11:55 PM Re: freegriff post# 129723 Post # of 129758 How much revenue has MANF produced? It was the reason why I took a stake in AMBS is 2012, however MANF is an untapped protein. While it achieved ODD, it was targeted for 1st in-man clinical studies in 2016 under Catalent Pharma who was hired to perform cGMP for clinical-grade production of MANF, but no progress was ever made. Its been around for decades, but has yet to make it out of preclinicals: https://www.researchgate.net/project/Discovery-of-MANF It sits in pre-clinicals 'proof of concept' for RP, RAO, AMD, DB, PK and MYO-CDI. If it truly holds the possibility of being a genuine game changer, then why hasn't Gerald advanced it forward given unlimited time and opportunities to do so?